Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Dec 01, 2020 4:08pm
166 Views
Post# 32011792

RE:QuestCap name change added testing sites & Webinar

RE:QuestCap name change added testing sites & WebinarWe calculate these revenue numbers genuinely. In the real world, $9,362,250 per month revenue is in USD and converting this to Canadian dollars become $9,362,250x1.30=$12,170,925. I usually leave revenue as USD on purpose, so it covers all those miscellaneous expenses. 

Sarb99 wrote:
December should bring a lot of updates and progress. QuestCap shareholder meeting day after tomorrow then comes to a name change. Adding 25 more testing sites starting this week. Then December 10, 2020, another webinar with more updates. 
 
QuestCap management said they are still aiming at 200-300 collections installed by Christmas and a lot more coming in January. 
 
Today news gave us simple math. Initial 20 sites showing strong test sales with a 7-day rolling average of 73 tests per day per testing site and average test price exceeding $95 per test; 20 sites x 73 test each day, each site = 1460x$95=$138,700 each day and $4,161,000 per month. Now with 45 testing sites 3285 tests each day and, each testing site 3285x95=$312,075 per day and $9,362,250 per month. 
 
Once you start adding these numbers with 100 testing sites making money or maybe 300 testing sites making money. 
 
Short time, yes, people can manipulate stock price but long term, no way. Even with 45 covid-19 testing sites up and running can bring over $9 million a month should be much higher than the $21 million market cap. 



<< Previous
Bullboard Posts
Next >>